Severity: Warning
Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Patients with saphenous vein graft (SVG) disease represent an increasing proportion of those referred for percutaneous coronary intervention. The success of treatment of occluded SVG with percutaneous intervention has been limited by frequent occurrence of no-reflow phenomenon. Use of self-expanding stents with low pressure pre- and post-dilation may improve success by limiting embolism of atherothrombotic debris. The self-expanding stents provide a meshed design that helps to trap the atherothrombotic debris between the vessel wall and stent struts. Results with two patients are described to illustrate the proposed technique that appears to limit no-reflow during and immediately after the procedure. Adjunctive treatment with a GP IIb-IIIa inhibitor is likely to be of benefit as well. Additional studies are required to demonstrate definitively the potential benefits of this approach.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00019501-200211000-00004 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!